EDP Sciences logo
Subscriber Authentication Point
rechercher
Menu
Accueil Tous les numéros Volume 213 / Numéro 1-2 (2019) Biologie Aujourd’hui, 213 1-2 (2019) 35-41 References
Free Access
Issue
Biologie Aujourd’hui
Volume 213, Number 1-2, 2019
Page(s) 35 - 41
DOI https://doi.org/10.1051/jbio/2019019
Published online 5 juillet 2019
  • Headache Classification Committee of the International Headache Society (IHS). (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38, 1-211. [Google Scholar]
  • Bose, P., Karsan, N., Goadsby, P.J. (2018). The migraine postdrome. Continuum (Minneap Minn), 24, 1023-1031. [PubMed] [Google Scholar]
  • Disease, G.B.D., Injury, I., Prevalence, C. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390, 1211-1259. [CrossRef] [PubMed] [Google Scholar]
  • Donnet, A., Emery, C., Aly, S., Allaf, B., Cayre, F., Mahieu, N., Gourmelen, J., Lévy, P., Fagnani, F. (2019). Migraine burden and costs in France: a nationwide claims database analysis of triptan users. J Med Econ, 1-9. [Google Scholar]
  • Goadsby, P.J., Holland, P.R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., Akerman, S. (2017). Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev, 97, 553-622. [Google Scholar]
  • Hepp, Z., Dodick, D.W., Varon, S.F., Chia, J., Matthew, N., Gillard, P., Hansen, R.N., Devine, E.B. (2017). Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: a retrospective claims analysis. Cephalalgia, 37, 470-485. [CrossRef] [PubMed] [Google Scholar]
  • Jackson, J.L., Cogbill, E., Santana-Davila, R., Eldredge, C., Collier, W., Gradall, A., Sehgal, N., Kuester, J. (2015). A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One, 10, e0130733. [CrossRef] [PubMed] [Google Scholar]
  • Jarvis, S., Dassan, P., Piercy, C.N. (2018). Managing migraine in pregnancy. BMJ, 360, k80. [Google Scholar]
  • Karsan, N., Bose, P., Goadsby, P.J. (2018). The migraine premonitory phase. Continuum (Minneap Minn) , 24, 996-1008. [PubMed] [Google Scholar]
  • Lampl, C., Buzath, A., Klinger, D., Neumann, K. (1999). Lamotrigine in the prophylactic treatment of migraine aura − a pilot study. Cephalalgia, 19, 58-63. [CrossRef] [PubMed] [Google Scholar]
  • Lampl, C., Thomas, H., Stovner, L.J., Tassorelli, C., Katsarava, Z., Lainez, J.M., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Andrée, C., Steiner, T.J. (2016). Interictal burden attributable to episodic headache: findings from the Eurolight project. J Headache Pain, 17, 9. [CrossRef] [PubMed] [Google Scholar]
  • Lantéri-Minet, M., Radat, F., Chautard, M.H., Lucas, C. (2005). Anxiety and depression associated with migraine: influence on migraine subjects’ disability and quality of life, and acute migraine management. Pain, 118, 319-326. [CrossRef] [PubMed] [Google Scholar]
  • Lantéri-Minet, M., Massiou, H., Romatet, S., Barba, A., Lucas, C., Allaf, B. (2011). An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT Study). Headache, 51, 590-601. [CrossRef] [PubMed] [Google Scholar]
  • Lantéri-Minet, M., Valade, D., Géraud, G., Lucas, C., Donnet, A. (2014). Revised French guidelines for the diagnosis and management of migraine in adults and children. J Headache Pain, 15, 2. [CrossRef] [PubMed] [Google Scholar]
  • Linde, M., Gustavsson, A., Stovner, L.J., Steiner, T.J., Barré, J., Katsarava, Z., Lainez, J.M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Andrée, C. (2012). The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol, 19, 703-711. [CrossRef] [PubMed] [Google Scholar]
  • Lipton, R.B., Bigal, M.E., Diamond, M., Freitag, F., Reed, M.L., Stewart, W.F., Group, A.A. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68, 343-349. [Google Scholar]
  • Mathew, N.T., Jaffri, S.F. (2009). A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache, 49, 1466-1478. [CrossRef] [PubMed] [Google Scholar]
  • Olsen, T.S. (1995). Pathophysiology of the migraine aura: the spreading depression theory. Brain , 118(Pt 1), 307-308. [CrossRef] [PubMed] [Google Scholar]
  • Rainero, I., Vacca, A., Govone, F., Gai, A., Pinessi, L., Rubino, E. (2018). Migraine: genetic variants and clinical phenotypes. Curr Med Chem. PMID: 30027842. [Google Scholar]
  • Russell, M.B., Ducros, A. (2011). Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol, 10, 457-470. [CrossRef] [PubMed] [Google Scholar]
  • Stovner, L.J., Zwart, J.A., Hagen, K., Terwindt, G.M., Pascual, J. (2006). Epidemiology of headache in Europe. Eur J Neurol, 13, 333-345. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.